Vaccine Effectiveness of RV1 in a Naïve Population
Sponsor: GlaxoSmithKline
A observational or N/A phase clinical study on Diarrhea and Gastroenteritis, this trial is completed. The trial is conducted by GlaxoSmithKline and has accumulated 14 data snapshots since 2012. Infectious disease trials contribute critical data for public health response and treatment development.
Status Flow
Change History
14 versions recorded-
Sep 2025 — Present [monthly]
Completed
-
Sep 2024 — Sep 2025 [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jan 2023 — Jul 2024 [monthly]
Completed
-
Dec 2022 — Jan 2023 [monthly]
Completed
▶ Show 9 earlier versions
-
Dec 2021 — Dec 2022 [monthly]
Completed
-
Jan 2021 — Dec 2021 [monthly]
Completed
-
Nov 2020 — Jan 2021 [monthly]
Completed
-
Oct 2019 — Nov 2020 [monthly]
Completed
-
Jun 2018 — Oct 2019 [monthly]
Completed
-
May 2018 — Jun 2018 [monthly]
Completed
-
Apr 2018 — May 2018 [monthly]
Completed
Phase: NA → None
-
Aug 2017 — Apr 2018 [monthly]
Completed NA
-
Jan 2017 — Aug 2017 [monthly]
Completed NA
First recorded
Feb 2012
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- GlaxoSmithKline
- Institut National en Santé Publique du Québec
- McGill University Health Centre/Research Institute of the McGill University Health Centre
- Ministere de la Sante et des Services Sociaux
For direct contact, visit the study record on ClinicalTrials.gov .